Skip to content
2000
Volume 21, Issue 2
  • ISSN: 1573-3971
  • E-ISSN: 1875-6360

Abstract

Obesity is a growing global health crisis intricately connected to various chronic conditions, including arthritis. This paper explores the intricate web of hormonal changes in the context of obesity and their profound influence on the development and progression of arthritis. Hormones, such as leptin, insulin, cortisol, and estrogen, all altered in obesity, play pivotal roles in inflammation, cartilage degradation, mechanical stress, and pain associated with obesity-related arthritis. Additionally, the mechanical stress placed on weight-bearing joints by excess body weight accelerates joint wear and tear, contributing to arthritis. Genetic factors, shared biomarkers, and pathways further link these conditions. Recognizing these connections is vital for healthcare professionals and individuals facing the challenges of obesity and arthritis, offering insights into strategies for prevention, management, and intervention. This comprehensive understanding of the complex interplay between hormonal changes, obesity, and arthritis sheds light on multifaceted mechanisms underlying this intricate relationship.

Loading

Article metrics loading...

/content/journals/crr/10.2174/0115733971293288240313090945
2024-04-15
2025-05-22
Loading full text...

Full text loading...

References

  1. HaslamD.W. JamesW.P.T. Obesity.Lancet200536694921197120910.1016/S0140‑6736(05)67483‑116198769
    [Google Scholar]
  2. MaglianoM. Obesity and arthritis.Menopause Int.200814414915410.1258/mi.2008.00801819037063
    [Google Scholar]
  3. SteinmetzJ.D. CulbrethG.T. HaileL.M. RaffertyQ. LoJ. FukutakiK.G. CruzJ.A. SmithA.E. VollsetS.E. BrooksP.M. CrossM. WoolfA.D. HaginsH. Abbasi-KangevariM. AbediA. AckermanI.N. AmuH. AntonyB. ArablooJ. AravkinA.Y. ArgawA.M. ArtamonovA.A. AshrafT. BarrowA. BearneL.M. BensenorI.M. BerhieA.Y. BhardwajN. BhardwajP. BhojarajaV.S. BijaniA. BriantP.S. BriggsA.M. ButtN.S. CharanJ. ChattuV.K. CicuttiniF.M. CoberlyK. DadrasO. DaiX. DandonaL. DandonaR. de LucaK. Denova-GutiérrezE. DharmaratneS.D. DhimalM. DianatinasabM. DreinhoeferK.E. ElhadiM. FarooqueU. FarpourH.R. FilipI. FischerF. FreitasM. GanesanB. GemedaB.N.B. GetachewT. GhamariS-H. GhashghaeeA. GillT.K. GolechhaM. GolinelliD. GuptaB. GuptaV.B. GuptaV.K. HaddadiR. Hafezi-NejadN. HalwaniR. HamidiS. HanifA. HarliantoN.I. HaroJ.M. HartvigsenJ. HayS.I. HebertJ.J. HeidariG. HosseiniM-S. HosseinzadehM. HsiaoA.K. IlicI.M. IlicM.D. JacobL. JayawardenaR. JhaR.P. JonasJ.B. JosephN. KandelH. KarayeI.M. KhanM.J. KimY.J. KolahiA-A. KorzhO. KoteeswaranR. KrishnamoorthyV. KumarG.A. KumarN. LeeS. LimS.S. LoboS.W. LucchettiG. MalekpourM-R. MalikA.A. Mandarano-FilhoL.G.G. MartiniS. MentisA-F.A. MesregahM.K. MestrovicT. MirrakhimovE.M. MisganawA. MohammadpourhodkiR. MokdadA.H. MomtazmaneshS. MorrisonS.D. MurrayC.J.L. NassereldineH. NetsereH.B. Neupane KandelS. OwolabiM.O. Panda-JonasS. PandeyA. PawarS. PedersiniP. PereiraJ. RadfarA. RashidiM-M. RawafD.L. RawafS. RawassizadehR. RayeganiS-M. RibeiroD. RoeverL. SaddikB. SahebkarA. SalehiS. Sanchez RieraL. SanmarchiF. Santric-MilicevicM.M. ShahabiS. ShaikhM.A. ShakerE. ShannawazM. SharmaR. SharmaS. ShettyJ.K. ShiriR. ShobeiriP. SilvaD.A.S. SinghA. SinghJ.A. SinghS. SkouS.T. SlaterH. Soltani-ZangbarM.S. StarodubovaA.V. Tehrani-BanihashemiA. Valadan TahbazS. ValdezP.R. VoB. VuL.G. WangY-P. Yahyazadeh JabbariS.H. YonemotoN. YunusaI. MarchL.M. OngK.L. VosT. KopecJ.A. Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: A systematic analysis for the Global Burden of Disease Study 2021.Lancet Rheumatol.202359e508e52210.1016/S2665‑9913(23)00163‑737675071
    [Google Scholar]
  4. ElluluM.S. PatimahI. Khaza’aiH. RahmatA. AbedY. Obesity and inflammation: The linking mechanism and the complications.Arch. Med. Sci.20174485186310.5114/aoms.2016.5892828721154
    [Google Scholar]
  5. KuckuckS. van der ValkE.S. ScheurinkA.J.W. LengtonR. MohseniM. VisserJ.A. IyerA.M. van den BergS.A.A. van RossumE.F.C. Levels of hormones regulating appetite and energy homeostasis in response to a 1.5-Year combined lifestyle intervention for obesity.Front. Physiol.202314101085810.3389/fphys.2023.101085836891140
    [Google Scholar]
  6. YanM. ZhangJ. YangH. SunY. The role of leptin in osteoarthritis.Medicine (Baltimore)20189714e025710.1097/MD.000000000001025729620639
    [Google Scholar]
  7. WondmkunY.T. Obesity, insulin resistance, and type 2 diabetes: Associations and therapeutic implications.Diabetes Metab. Syndr. Obes.2020133611361610.2147/DMSO.S27589833116712
    [Google Scholar]
  8. HannibalK.E. BishopM.D. Chronic stress, cortisol dysfunction, and pain: A psychoneuroendocrine rationale for stress management in pain rehabilitation.Phys. Ther.201494121816182510.2522/ptj.2013059725035267
    [Google Scholar]
  9. Roman-BlasJ.A. CastañedaS. LargoR. Herrero-BeaumontG. Osteoarthritis associated with estrogen deficiency.Arthritis Res. Ther.200911524110.1186/ar279119804619
    [Google Scholar]
  10. CorrêaL.H. HeynG.S. MagalhaesK.G. The impact of the adipose organ plasticity on inflammation and cancer progression.Cells20198766210.3390/cells807066231262098
    [Google Scholar]
  11. RosenwaldM. WolfrumC. The origin and definition of brite versus white and classical brown adipocytes.Adipocyte2014314910.4161/adip.2623224575363
    [Google Scholar]
  12. ChaitA. den HartighL.J. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease.Front. Cardiovasc. Med.202072210.3389/fcvm.2020.0002232158768
    [Google Scholar]
  13. BalistreriC.R. CarusoC. CandoreG. The role of adipose tissue and adipokines in obesity-related inflammatory diseases.Mediators Inflamm.2010201011910.1155/2010/80207820671929
    [Google Scholar]
  14. LuZ. LiY. SongJ. Characterization and treatment of inflammation and insulin resistance in obese adipose tissue.Diabetes Metab. Syndr. Obes.2020133449346010.2147/DMSO.S27150933061505
    [Google Scholar]
  15. KernL. MittenbühlerM. VestingA. OstermannA. WunderlichC. WunderlichF. Obesity-induced TNFα and IL-6 signaling: The missing link between obesity and inflammation—driven liver and colorectal cancers.Cancers (Basel)20181112410.3390/cancers1101002430591653
    [Google Scholar]
  16. WangT. HeC. Pro-inflammatory cytokines: The link between obesity and osteoarthritis.Cytokine Growth Factor Rev.201844385010.1016/j.cytogfr.2018.10.00230340925
    [Google Scholar]
  17. LeeM.J. WuY. FriedS.K. Adipose tissue remodeling in pathophysiology of obesity.Curr. Opin. Clin. Nutr. Metab. Care201013437137610.1097/MCO.0b013e32833aabef20531178
    [Google Scholar]
  18. FusterJ.J. OuchiN. GokceN. WalshK. Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease.Circ. Res.2016118111786180710.1161/CIRCRESAHA.115.30688527230642
    [Google Scholar]
  19. HamiltonKJ HewittSC AraoY KorachKS Estrogen hormone biology.Curr Top Dev Biol.20171251110914610.1016/bs.ctdb.2016.12.005
    [Google Scholar]
  20. LizcanoF. GuzmánG. Estrogen deficiency and the origin of obesity during menopause.BioMed Res. Int.2014201411110.1155/2014/75746124734243
    [Google Scholar]
  21. GrossmannM. Tang FuiM.N. DupuisP. Lowered testosterone in male obesity: Mechanisms, morbidity and management.Asian J. Androl.201416222323110.4103/1008‑682X.12236524407187
    [Google Scholar]
  22. IzquierdoA.G. CrujeirasA.B. CasanuevaF.F. CarreiraM.C. Leptin, obesity, and leptin resistance: Where are we 25 years later?Nutrients20191111270410.3390/nu1111270431717265
    [Google Scholar]
  23. ParidaS. SiddharthS. SharmaD. Adiponectin, obesity, and cancer: Clash of the bigwigs in health and disease.Int. J. Mol. Sci.20192010251910.3390/ijms2010251931121868
    [Google Scholar]
  24. PivaS.R. SuskoA.M. KhojaS.S. JosbenoD.A. FitzgeraldG.K. ToledoF.G.S. Links between osteoarthritis and diabetes: Implications for management from a physical activity perspective.Clin. Geriatr. Med.20153116787, viii10.1016/j.cger.2014.08.01925453302
    [Google Scholar]
  25. Akeel Al-hussaniyH. Hikmate AlburghaifA. Akeel NajiM. Leptin hormone and its effectiveness in reproduction, metabolism, immunity, diabetes, hopes and ambitions.J. Med. Life202114560060510.25122/jml‑2021‑015335027962
    [Google Scholar]
  26. OuerghiN. FekiM. BragazziN.L. KnechtleB. HillL. NikolaidisP.T. BouassidaA. Ghrelin response to acute and chronic exercise: Insights and implications from a systematic review of the literature.Sports Med.202151112389241010.1007/s40279‑021‑01518‑634374968
    [Google Scholar]
  27. JanssenJ.A.M.J.L. Hyperinsulinemia and its pivotal role in aging, obesity, type 2 diabetes, cardiovascular disease and cancer.Int. J. Mol. Sci.20212215779710.3390/ijms2215779734360563
    [Google Scholar]
  28. Diep NguyenT.M. Adiponectin: Role in physiology and pathophysiology.Int. J. Prev. Med.202011113610.4103/ijpvm.IJPVM_193_2033088464
    [Google Scholar]
  29. van der ValkE.S. SavasM. van RossumE.F.C. Stress and obesity: Are there more susceptible individuals?Curr. Obes. Rep.20187219320310.1007/s13679‑018‑0306‑y29663153
    [Google Scholar]
  30. MullurR. LiuY.Y. BrentG.A. Thyroid hormone regulation of metabolism.Physiol. Rev.201494235538210.1152/physrev.00030.201324692351
    [Google Scholar]
  31. KuryłowiczA. Estrogens in adipose tissue physiology and obesity-related dysfunction.Biomedicines202311369010.3390/biomedicines1103069036979669
    [Google Scholar]
  32. DavyK.P. OrrJ.S. Sympathetic nervous system behavior in human obesity.Neurosci. Biobehav. Rev.200933211612410.1016/j.neubiorev.2008.05.02418602694
    [Google Scholar]
  33. KimT.W. JeongJ.H. HongS.C. The impact of sleep and circadian disturbance on hormones and metabolism.Int. J. Endocrinol.201520151910.1155/2015/59172925861266
    [Google Scholar]
  34. ChenL. DengH. CuiH. FangJ. ZuoZ. DengJ. LiY. WangX. ZhaoL. Inflammatory responses and inflammation-associated diseases in organs.Oncotarget2018967204721810.18632/oncotarget.2320829467962
    [Google Scholar]
  35. JangD. LeeA.H. ShinH.Y. SongH.R. ParkJ.H. KangT.B. LeeS.R. YangS.H. The role of tumor necrosis factor alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics.Int. J. Mol. Sci.2021225271910.3390/ijms2205271933800290
    [Google Scholar]
  36. WojdasiewiczP. PoniatowskiŁ.A. SzukiewiczD. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.Mediators Inflamm.2014201411910.1155/2014/56145924876674
    [Google Scholar]
  37. TanakaT. NarazakiM. KishimotoT. IL-6 in inflammation, immunity, and disease.Cold Spring Harb. Perspect. Biol.2014610a016295a01629510.1101/cshperspect.a01629525190079
    [Google Scholar]
  38. McGeachyM.J. CuaD.J. GaffenS.L. The IL-17 family of cytokines in health and disease.Immunity201950489290610.1016/j.immuni.2019.03.02130995505
    [Google Scholar]
  39. IhimS.A. AbubakarS.D. ZianZ. SasakiT. SaffariounM. MalekniaS. AziziG. Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment.Front. Immunol.20221391997310.3389/fimmu.2022.91997336032110
    [Google Scholar]
  40. DongY. ZhongJ. DongL. IL-33 in rheumatic diseases.Front. Med. (Lausanne)2021873948910.3389/fmed.2021.73948934589505
    [Google Scholar]
  41. FrangogiannisN.G. Transforming growth factor–β in tissue fibrosis.J. Exp. Med.20202173e2019010310.1084/jem.2019010332997468
    [Google Scholar]
  42. ShibuyaM. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: A crucial target for anti- and pro-angiogenic therapies.Genes Cancer20112121097110510.1177/194760191142303122866201
    [Google Scholar]
  43. PortaS. Otero-LosadaM. Kölliker FrersR.A. CosentinoV. KerzbergE. CapaniF. Adipokines, cardiovascular risk, and therapeutic management in obesity and psoriatic arthritis.Front. Immunol.20211159074910.3389/fimmu.2020.59074933643281
    [Google Scholar]
  44. RaineC. GilesI. What is the impact of sex hormones on the pathogenesis of rheumatoid arthritis?Front. Med. (Lausanne)2022990987910.3389/fmed.2022.90987935935802
    [Google Scholar]
  45. WuH. BallantyneC.M. Metabolic inflammation and insulin resistance in obesity.Circ. Res.2020126111549156410.1161/CIRCRESAHA.119.31589632437299
    [Google Scholar]
  46. HardyO.T. CzechM.P. CorveraS. What causes the insulin resistance underlying obesity?Curr. Opin. Endocrinol. Diabetes Obes.2012192818710.1097/MED.0b013e3283514e1322327367
    [Google Scholar]
  47. TantiJ.F. CeppoF. JagerJ. BerthouF. Implication of inflammatory signaling pathways in obesity-induced insulin resistance.Front. Endocrinol. (Lausanne)2013318110.3389/fendo.2012.0018123316186
    [Google Scholar]
  48. JungU. ChoiM.S. Obesity and its metabolic complications: The role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.Int. J. Mol. Sci.20141546184622310.3390/ijms1504618424733068
    [Google Scholar]
  49. KumarR. MalK. RazaqM.K. MagsiM. MemonM.K. MemonS. AfrozM.N. SiddiquiH.F. RizwanA. Association of leptin with obesity and insulin resistance.Cureus20201212e1217810.7759/cureus.1217833489589
    [Google Scholar]
  50. SzukiewiczD. Molecular mechanisms for the vicious cycle between insulin resistance and the inflammatory response in obesity.Int. J. Mol. Sci.20232412981810.3390/ijms2412981837372966
    [Google Scholar]
  51. OrmazabalV. NairS. ElfekyO. AguayoC. SalomonC. ZuñigaF.A. Association between insulin resistance and the development of cardiovascular disease.Cardiovasc. Diabetol.201817112210.1186/s12933‑018‑0762‑430170598
    [Google Scholar]
  52. BertoldoE. AdamiG. RossiniM. GiolloA. OrsoliniG. ViapianaO. GattiD. FassioA. The emerging roles of endocrine hormones in different arthritic disorders.Front. Endocrinol. (Lausanne)20211262092010.3389/fendo.2021.62092034093428
    [Google Scholar]
  53. NielsenR.H. ChristiansenC. StolinaM. KarsdalM.A. Oestrogen exhibits type II collagen protective effects and attenuates collagen-induced arthritis in rats.Clin. Exp. Immunol.20081521212710.1111/j.1365‑2249.2008.03594.x18241229
    [Google Scholar]
  54. HardingA.T. HeatonN.S. The impact of estrogens and their receptors on immunity and inflammation during infection.Cancers (Basel)202214490910.3390/cancers1404090935205657
    [Google Scholar]
  55. DuN. SongL. LiY. WangT. FangQ. OuJ. NandakumarK.S. Phytoestrogens protect joints in collagen induced arthritis by increasing IgG glycosylation and reducing osteoclast activation.Int. Immunopharmacol.20208310638710.1016/j.intimp.2020.10638732172207
    [Google Scholar]
  56. XuX. LiX. LiangY. OuY. HuangJ. XiongJ. DuanL. WangD. Estrogen modulates cartilage and subchondral bone remodeling in an ovariectomized rat model of postmenopausal osteoarthritis.Med. Sci. Monit.2019253146315310.12659/MSM.91625431031401
    [Google Scholar]
  57. Alcaide-RuggieroL. CugatR. DomínguezJ.M. Proteoglycans in articular cartilage and their contribution to chondral injury and repair mechanisms.Int. J. Mol. Sci.202324131082410.3390/ijms24131082437446002
    [Google Scholar]
  58. ChlebowskiR.T. CirilloD.J. EatonC.B. StefanickM.L. PettingerM. CarboneL.D. JohnsonK.C. SimonM.S. WoodsN.F. Wactawski-WendeJ. Estrogen alone and joint symptoms in the women’s health initiative randomized trial.Menopause201320660060810.1097/GME.0b013e31828392c423511705
    [Google Scholar]
  59. ShahL. ElshaikhA.O. LeeR. Joy MathewC. JoseM.T. CancarevicI. Do Menopause and aging affect the onset and progression of rheumatoid arthritis and systemic lupus erythematosus?Cureus20201210e1094410.7759/cureus.1094433072443
    [Google Scholar]
  60. DingS. MaduC.O. LuY. The impact of hormonal imbalances associated with obesity on the incidence of endometrial cancer in postmenopausal women.J. Cancer202011185456546510.7150/jca.4758032742493
    [Google Scholar]
  61. MairK.M. GawR. MacLeanM.R. Obesity, estrogens and adipose tissue dysfunction – implications for pulmonary arterial hypertension.Pulm. Circ.202010312110.1177/204589402095202332999709
    [Google Scholar]
  62. HindsJ.A. SanchezE.R. The role of the hypothalamus–pituitary–adrenal (HPA) axis in test-induced anxiety: assessments, physiological responses, and molecular details.Stresses20222114615510.3390/stresses2010011
    [Google Scholar]
  63. MacfarlaneE. SeibelM.J. ZhouH. Arthritis and the role of endogenous glucocorticoids.Bone Res.2020813310.1038/s41413‑020‑00112‑232963891
    [Google Scholar]
  64. SeifF. KhoshmirsafaM. AazamiH. MohsenzadeganM. SedighiG. BaharM. The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells.Cell Commun. Signal.20171512310.1186/s12964‑017‑0177‑y28637459
    [Google Scholar]
  65. MorrisR. KershawN.J. BabonJ.J. The molecular details of cytokine signaling via the JAK/STAT pathway.Protein Sci.201827121984200910.1002/pro.351930267440
    [Google Scholar]
  66. KanyS. VollrathJ.T. ReljaB. Cytokines in inflammatory disease.Int. J. Mol. Sci.20192023600810.3390/ijms2023600831795299
    [Google Scholar]
  67. TanakaY. LuoY. O’SheaJ.J. NakayamadaS. Janus kinase-targeting therapies in rheumatology: A mechanisms-based approach.Nat. Rev. Rheumatol.202218313314510.1038/s41584‑021‑00726‑834987201
    [Google Scholar]
  68. CargnelloM. RouxP.P. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.Microbiol. Mol. Biol. Rev.2011751508310.1128/MMBR.00031‑1021372320
    [Google Scholar]
  69. Al-MansooriL. Al-JaberH. PrinceM.S. ElrayessM.A. Role of inflammatory cytokines, growth factors and adipokines in adipogenesis and insulin resistance.Inflammation2022451314410.1007/s10753‑021‑01559‑z34536157
    [Google Scholar]
  70. ShiC. ZhuL. ChenX. GuN. ChenL. ZhuL. YangL. PangL. GuoX. JiC. ZhangC. IL-6 and TNF-α induced obesity-related inflammatory response through transcriptional regulation of miR-146b.J. Interferon Cytokine Res.201434534234810.1089/jir.2013.007824428800
    [Google Scholar]
  71. OeckinghausA. GhoshS. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb. Perspect. Biol.200914a000034a00003410.1101/cshperspect.a00003420066092
    [Google Scholar]
  72. LiuT. ZhangL. JooD. SunS.C. NF-κB signaling in inflammation.Signal Transduct. Target. Ther.2017211702310.1038/sigtrans.2017.2329158945
    [Google Scholar]
  73. HiranoT. IL-6 in inflammation, autoimmunity and cancer.Int. Immunol.202133312714810.1093/intimm/dxaa07833337480
    [Google Scholar]
  74. YuH. LinL. ZhangZ. ZhangH. HuH. Targeting NF-κB pathway for the therapy of diseases: Mechanism and clinical study.Signal Transduct. Target. Ther.20205120910.1038/s41392‑020‑00312‑632958760
    [Google Scholar]
  75. RoyT. BoatengS.T. UddinM.B. Banang-MbeumiS. YadavR.K. BockC.R. FolahanJ.T. Siwe-NoundouX. WalkerA.L. KingJ.A. BuergerC. HuangS. ChamcheuJ.C. The PI3K-Akt-mTOR and associated signaling pathways as molecular drivers of immune-mediated inflammatory skin diseases: Update on therapeutic strategy using natural and synthetic compounds.Cells20231212167110.3390/cells1212167137371141
    [Google Scholar]
  76. YangJ. NieJ. MaX. WeiY. PengY. WeiX. Targeting PI3K in cancer: Mechanisms and advances in clinical trials.Mol. Cancer20191812610.1186/s12943‑019‑0954‑x30782187
    [Google Scholar]
  77. ZhaoJ. JiangP. GuoS. SchrodiS.J. HeD. Apoptosis, autophagy, netosis, necroptosis, and pyroptosis mediated programmed cell death as targets for innovative therapy in Rheumatoid arthritis.Front. Immunol.20211280980610.3389/fimmu.2021.80980635003139
    [Google Scholar]
  78. FangQ. ZhouC. NandakumarK.S. Molecular and cellular pathways contributing to joint damage in Rheumatoid arthritis.Mediators Inflamm.2020202012010.1155/2020/383021232256192
    [Google Scholar]
  79. KararJ. MaityA. PI3K/AKT/mTOR pathway in angiogenesis.Front. Mol. Neurosci.201145110.3389/fnmol.2011.0005122144946
    [Google Scholar]
  80. HuangX. LiuG. GuoJ. SuZ. The PI3K/AKT pathway in obesity and type 2 diabetes.Int. J. Biol. Sci.201814111483149610.7150/ijbs.2717330263000
    [Google Scholar]
  81. SprostonN.R. AshworthJ.J. Role of C-reactive protein at sites of inflammation and infection.Front. Immunol.2018975410.3389/fimmu.2018.0075429706967
    [Google Scholar]
  82. Clemente-SuárezV.J. Redondo-FlórezL. Beltrán-VelascoA.I. Martín-RodríguezA. Martínez-GuardadoI. Navarro-JiménezE. Laborde-CárdenasC.C. Tornero-AguileraJ.F. The role of adipokines in health and disease.Biomedicines2023115129010.3390/biomedicines1105129037238961
    [Google Scholar]
  83. LiuS. DengZ. ChenK. JianS. ZhouF. YangY. FuZ. XieH. XiongJ. ZhuW. Cartilage tissue engineering: From proinflammatory and anti-inflammatory cytokines to osteoarthritis treatments (Review).Mol. Med. Rep.20222539910.3892/mmr.2022.1261535088882
    [Google Scholar]
  84. QuD. LiuJ. LauC.W. HuangY. IL -6 in diabetes and cardiovascular complications.Br. J. Pharmacol.2014171153595360310.1111/bph.1271324697653
    [Google Scholar]
  85. ZeddouM. Osteoarthritis is a low-grade inflammatory disease: Obesity’s involvement and herbal treatment.Evid. Based Complement. Alternat. Med.2019201911110.1155/2019/203748431781260
    [Google Scholar]
  86. Cabral-PachecoG.A. Garza-VelozI. Castruita-De la RosaC. Ramirez-AcuñaJ.M. Perez-RomeroB.A. Guerrero-RodriguezJ.F. Martinez-AvilaN. Martinez-FierroM.L. The roles of matrix metalloproteinases and their inhibitors in human diseases.Int. J. Mol. Sci.20202124973910.3390/ijms2124973933419373
    [Google Scholar]
  87. FamitafreshiH. KarimianM. Prostaglandins as the agents that modulate the course of brain disorders.Degener. Neurol. Neuromuscul. Dis.20201011310.2147/DNND.S24080032021549
    [Google Scholar]
  88. WooJ. Koziol-WhiteC. PanettieriR.Jr JudeJ. TGF-β: The missing link in obesity-associated airway diseases?Curr Pharmacol Drug Discov2021210001610.1016/j.crphar.2021.10001634909651
    [Google Scholar]
  89. SungH.K. DohK.O. SonJ.E. ParkJ.G. BaeY. ChoiS. NelsonS.M.L. CowlingR. NagyK. MichaelI.P. KohG.Y. AdamsonS.L. PawsonT. NagyA. Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis.Cell Metab.2013171617210.1016/j.cmet.2012.12.01023312284
    [Google Scholar]
  90. RecinellaL. OrlandoG. FerranteC. ChiavaroliA. BrunettiL. LeoneS. Adipokines: New potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases.Front. Physiol.20201157896610.3389/fphys.2020.57896633192583
    [Google Scholar]
  91. ZorenaK. Jachimowicz-DudaO. ŚlęzakD. RobakowskaM. MrugaczM. Adipokines and obesity. Potential link to metabolic disorders and chronic complications.Int. J. Mol. Sci.20202110357010.3390/ijms2110357032443588
    [Google Scholar]
  92. Abou-SamraM. SelvaisC.M. DubuissonN. BrichardS.M. Adiponectin and its mimics on skeletal muscle: Insulin sensitizers, fat burners, exercise mimickers, muscling pills … or everything together?Int. J. Mol. Sci.2020217262010.3390/ijms2107262032283840
    [Google Scholar]
  93. BokarewaM. NagaevI. DahlbergL. SmithU. TarkowskiA. Resistin, an adipokine with potent proinflammatory properties.J. Immunol.200517495789579510.4049/jimmunol.174.9.578915843582
    [Google Scholar]
  94. ToussirotE. Mini-review: The contribution of adipokines to joint inflammation in inflammatory rheumatic diseases.Front. Endocrinol. (Lausanne)20201160656010.3389/fendo.2020.60656033424772
    [Google Scholar]
  95. JarlborgM. GabayC. Systemic effects of IL-6 blockade in rheumatoid arthritis beyond the joints.Cytokine202214915574210.1016/j.cyto.2021.15574234688020
    [Google Scholar]
  96. VincentH.K. HeywoodK. ConnellyJ. HurleyR.W. Obesity and weight loss in the treatment and prevention of osteoarthritis.PM R201245SSuppl.S59S6710.1016/j.pmrj.2012.01.00522632704
    [Google Scholar]
  97. ChaoA.M. QuigleyK.M. WaddenT.A. Dietary interventions for obesity: Clinical and mechanistic findings.J. Clin. Invest.20211311e14006510.1172/JCI14006533393504
    [Google Scholar]
  98. GrossoG. LaudisioD. Frias-ToralE. BarreaL. MuscogiuriG. SavastanoS. ColaoA. Anti-inflammatory nutrients and obesity-associated metabolic-inflammation: State of the art and future direction.Nutrients2022146113710.3390/nu1406113735334794
    [Google Scholar]
  99. DochertyS. HarleyR. McAuleyJ.J. CroweL.A.N. PedretC. KirwanP.D. SiebertS. MillarN.L. The effect of exercise on cytokines: Implications for musculoskeletal health: A narrative review.BMC Sports Sci. Med. Rehabil.2022141510.1186/s13102‑022‑00397‑234991697
    [Google Scholar]
  100. LinY. FanR. HaoZ. LiJ. YangX. ZhangY. XiaY. The association between physical activity and insulin level under different levels of lipid indices and serum uric acid.Front. Physiol.20221380966910.3389/fphys.2022.80966935185617
    [Google Scholar]
  101. DaubenmierJ. KristellerJ. HechtF.M. ManingerN. KuwataM. JhaveriK. LustigR.H. KemenyM. KaranL. EpelE. Mindfulness intervention for stress eating to reduce cortisol and abdominal fat among overweight and obese women: An exploratory randomized controlled study.J. Obes.2011201111310.1155/2011/65193621977314
    [Google Scholar]
  102. ManningS. PucciA. FinerN. Pharmacotherapy for obesity: Novel agents and paradigms.Ther. Adv. Chronic Dis.20145313514810.1177/204062231452284824790728
    [Google Scholar]
/content/journals/crr/10.2174/0115733971293288240313090945
Loading
/content/journals/crr/10.2174/0115733971293288240313090945
Loading

Data & Media loading...


  • Article Type:
    Review Article
Keyword(s): arthritis; chronic pain; estrogen; hormonal changes; mechanical stress; Obesity
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test